CLASS II ONGOING Drug recall · Reported 11 Oct 2023 · FDA Enforcement Report
Triamcinolone Acetonide Injectable Suspension recalled by Eugia US
Eugia US is recalling Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per (40mg/mL) Multiple Dose, distributed nationwide in the US. The recall was initiated on 28 Sep 2023 and the FDA has classified it as Class II.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
- Recall number
- D-0041-2024
- FDA event ID
- 93128
- Recalling firm
- Eugia US, East Windsor, NJ
- Manufacturer
- Eugia US LLC
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 28 Sep 2023
- FDA classified
- 5 Oct 2023
- Reported
- 11 Oct 2023
- Type
- Voluntary: Firm initiated
- Customers notified by
- N/A
- Reason category
- Particulate Matter
- Drug class
- Injectable & IV Drugs
Timeline
| 28 Sep 2023 | Recall initiated by company | |
| 5 Oct 2023 | Classified by FDA | +7 days |
| 11 Oct 2023 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Product as listed by the FDA
Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per 10 mL (40mg/mL), 10 mL Multiple Dose Vial, Rx Only, For Intramuscular or Intra-articular use only, Shake Well, Not for IV/ID, intraocular, epidural, or intrathecal use, Mfd. in India for Auromedics Pharma LLC., E Windsor, NJ, 08520, NDC 55150-385-01.
Where it was distributed
Nationwide in the USA
Questions about this recall
Is Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per (40mg/mL) Multiple Dose recalled?
Yes. Eugia US recalled Triamcinolone Acetonide Injectable Suspension, USP, 400 mg per (40mg/mL) Multiple Dose on 28 Sep 2023. The recall is Class II and its status is Ongoing. Recall number D-0041-2024.
Why was it recalled?
Presence of Particulate Matter: A product complaint of a piece of glass was identified in a vial. The piece of glass appears to be roughly 1 cm x 0.5 cm inside the vial.
Which lots are affected?
Lot #: 3TC22010, Exp 11/30/2024
Where was it sold?
Nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Eugia US
All 17| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Lidocaine HCl Injection, USP 2%, 40 mg recalled by Eugia USLidolog Kit | Eugia US | Other | Nationwide |
| Drug | CLASS II | Gentamicin Injection, USP, (Pediatric), 20 mg recalled by Eugia USGentamicin | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Tirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofiban | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Tirofiban Hydrochloride Injection 5 mg recalled by Eugia USTirofiban | Eugia US | Potency & Assay | Nationwide |
| Drug | CLASS II | Testosterone Cypionate Injection, USP, CIII, 200mg per mL recalledTestosterone Cypionate | Eugia US | Manufacturing (CGMP) Deviations | Nationwide |
Other Triamcinolone Acetonide recalls
All 16| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS III | Triamcinolone Acetonide Cream recalled by Padagis US | Padagis US | Potency & Assay | Nationwide |
| Drug | CLASS II | Triamcinolone Acetonide Cream USP, 1% tube recalled by Padagis USTriamcinolone Acetonide | Padagis US | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Triamcinolone Acetonide cream, USP, 1% tube recalledTriamcinolone Acetonide | Mckesson Medical-Surgical Inc. Corporate Office | Manufacturing (CGMP) Deviations | Nationwide |
| Drug | CLASS II | Triamcinolone Acetonide Lotion recalled by Teligent Pharma | Teligent Pharma | Potency & Assay | Nationwide |
| Drug | CLASS II | Triamcinolone Acetonide Ointment recalled by Teligent Pharma | Teligent Pharma | Potency & Assay | Nationwide |